R
Richard M. Hoffman
Researcher at Roy J. and Lucille A. Carver College of Medicine
Publications - 210
Citations - 10684
Richard M. Hoffman is an academic researcher from Roy J. and Lucille A. Carver College of Medicine. The author has contributed to research in topics: Prostate cancer & Population. The author has an hindex of 49, co-authored 197 publications receiving 9923 citations. Previous affiliations of Richard M. Hoffman include University of Arizona & University of New Mexico.
Papers
More filters
Journal ArticleDOI
Comparing the effect of a decision aid plus patient navigation with usual care on colorectal cancer screening completion in vulnerable populations: study protocol for a randomized controlled trial.
Alison T. Brenner,Christina M. Getrich,Michael Pignone,Robert L. Rhyne,Richard M. Hoffman,Andrew McWilliams,Brisa Urquieta de Hernandez,Mark A. Weaver,Hazel Tapp,Khalil Harbi,Daniel S. Reuland +10 more
TL;DR: This pragmatic randomized controlled trial will test a combined decision aid and patient navigator intervention targeting CRC screening completion in diverse populations of vulnerable primary care patients and to reduce screening disparities.
Journal ArticleDOI
Comparative effectiveness research in localized prostate cancer treatment.
TL;DR: Comparative effectiveness research, using observational cohorts, claims data and simulation models, enables comparisons of treatments that have not been studied in controlled trials and captures real-world outcomes data to better support informed decision-making.
Journal ArticleDOI
Randomized trial results did not resolve controversies surrounding prostate cancer screening.
TL;DR: The randomized trials suggest that screening at best will have a small survival benefit but substantial potential risk for overdiagnosis and overtreatment, and patients need to understand these tradeoffs in order to make informed decisions about screening.
Journal ArticleDOI
Screening Coverage Needed to Reduce Mortality from Prostate Cancer: A Living Systematic Review
TL;DR: The quality of evidence is downgraded to moderate due to the retrospective identification of subgroups and limited data on control group screening, and the benefit of screening for prostate cancer compares favorably with screening for other cancers.
Journal Article
PEER REVIEWED: New Mexico’s Capacity for Increasing the Prevalence of Colorectal Cancer Screening With Screening Colonoscopies
Richard M. Hoffman,S. Noell Stone,Carla J. Herman,Ann Moore Jung,Jane Cotner,David K. Espey,Richard Kozoll,Michael Gavin +7 more
TL;DR: Implementing a screening colonoscopy strategy could achieve the goal of a higher level of colorectal screening, however, achieving more universal screening would require additional testing modalities.